https://www.marketscreener.com/quote/stock/ELI-LILLY-AND-COMPANY-13401/news/FDA-Approves-Verzenio-abemaciclib-as-the-First-and-Only-CDK4-6-Inhibitor-for-Certain-People-with-36681034/?utm_source=telegram&utm_medium=social&utm_campaign=share